From Aptamer Group May 16 2025 Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, has announced two new development contracts for Optimer binders and the agreement of licensing heads of terms with a global provider of specialty enzymes for developed enzyme-modulating Optimers. These engagements reflect ongoing collaborative relationships with established partners and highlight the utility of the Optimer platform for